Optimizing the outcome for patients with rectal cancer

Diseases of the Colon and Rectum

Volumn 46, Issue 3, 2003, Pages 389-402

  Gibbs, Peter ^a   Chao, Michael W ^a   Tjandra, Joe J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Adjuvant; Cancer; Chemotherapy; Magnetic resonance imaging; Radiotherapy; Rectal; Staging; Surgery; Ultrasound

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

ANUS SPHINCTER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIARRHEA; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; ENDORECTAL ULTRASOUND; ERYTHEMA; FEMUR NECK FRACTURE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; INTESTINE INJURY; LETHARGY; LYMPH NODE METASTASIS; META ANALYSIS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PELVIS CANCER; PELVIS FRACTURE; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; RECTUM BIOPSY; RECTUM CANCER; RECTUM FISTULA; RECTUM INJURY; RECTUM PERFORATION; RECTUM SURGERY; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN TOXICITY; SURGICAL TECHNIQUE; SURVIVAL RATE; THREE DIMENSIONAL IMAGING; VOMITING;

COLECTOMY; COMBINED MODALITY THERAPY; ENDOSONOGRAPHY; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PHYSICAL EXAMINATION; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0037340593     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6561-x     Document Type: Review

References (133)

1. Speck RL, Thomas WH, Larson RA, Wright HK, Cleveland JC. Analysis of 860 patients with carcinoma of the transverse and descending colon. Surg Gynecol Obstet 1970;130:259-62.
2. Sengupta S, Tjandra JJ. Local excision of rectal cancer: what is the evidence? Dis Colon Rectum 2001;44:1345-61.
3. Nicholls RJ, Mason AY, Morson BC, Dixon AK, Fry IK. The clinical staging of rectal cancer. Br J Surg 1982;69:404-9.
4. Bailey HR, Huval WV, Max E, Smith KW, Butts DR, Zamora LF. Local excision of carcinoma of the rectum for cure. Surgery 1992;111:555-61.
5. Taylor RH, Hay JH, Larsson SN. Transanal local excision of selected low rectal cancers. Am J Surg 1998;175:360-3.
6. Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal carcinomas (T1): transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996;39:969-76.
7. Konishi F, Muto T, Takahashi H, Itoh K, Kanazawa K, Morioka Y. Transrectal ultrasonography for the assessment of invasion of rectal carcinoma. Dis Colon Rectum 1985;28:889-94.
8. Orrom WJ, Wong WD, Rothenberger DA, Jensen LL, Goldberg SM. Endorectal ultrasound in the preoperative staging of rectal tumors. A learning experience. Dis Colon Rectum 1990;33:654-9.
9. Kim DG, Madoff RD. Transanal treatment of rectal cancer: ablative methods and open resection. Semin Surg Oncol 1998;15:101-13.
10. Beynon J, Foy DM, Roe AM, Temple LN, Mortensen NJ. Endoluminal ultrasound in the assessment of local invasion in rectal cancer. Br J Surg 1986;73:474-7.
11. Beynon J, Mortensen NJ, Foy DM, Channer JL, Virjee J, Goddard P. Pre-operative assessment of local invasion in rectal cancer: digital examination, endoluminal sonography or computed tomography? Br J Surg 1986;73:1015-7.
12. Milsom JW, Lavery IC, Stolfi VM, et al. The expanding utility of endoluminal ultrasonography in the management of rectal cancer. Surgery 1992;112:832-40.
13. Romano G, de Rosa P, Vallone G, Rotondo A, Grassi R, Santangelo ML. Intrarectal ultrasound and computed tomography in the pre- and postoperative assessment of patients with rectal cancer. Br J Surg 1985;72:S117-9.
14. Herzog U, von Flue M, Tondelli P, Schuppisser JP. How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? Dis Colon Rectum 1993;36:127-34.
15. Hulsmans FJ, Tio TL, Fockens P, Bosma A, Tytgat GN. Assessment of tumor infiltration depth in rectal cancer with transrectal sonography: caution is necessary. Radiology 1994;190:715-20.
16. Beynon J, Mortensen NJ, Foy DM, Channer JL, Rigby H, Virjee J. Preoperative assessment of mesorectal lymph node involvement in rectal cancer. Br J Surg 1989;76:276-9.
17. Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound. Dis Colon Rectum 1985;28:42-6.
18. Fleshman JW, Myerson RJ, Fry RD, Kodner II. Accuracy of transrectal ultrasound in predicting pathologic stage of rectal cancer before and after preoperative radiation therapy. Dis Colon Rectum 1992;35:823-9.
19. Hunerbein M, Schlag PM. Three-dimensional endosonography for staging of rectal cancer. Ann Surg 1997;225:432-8.
20. Hunerbein M, Below C, Schlag PM. Three-dimensional endorectal ultrasonography for staging of obstructing rectal cancer. Dis Colon Rectum 1996;39:636-42.
21. Guinet C, Buy JN, Ghossain MA, et al. Comparison of magnetic resonance imaging and computed tomography in the preoperative staging of rectal cancer. Arch Surg 1990;125:385-8.
22. Dixon AK, Fry IK, Morson BC, Nicholls RJ, Mason AY. Pre-operative computed tomography of carcinoma of the rectum. Br J Radiol 1981;54:655-9.
23. Waizer A, Zitron S, Ben-Baruch D, Baniel J, Wolloch Y, Dintsman M. Comparative study for preoperative staging of rectal cancer. Dis Colon Rectum 1989;32:53-6.
24. Wallengren NO, Holtas S, Andren-Sandberg A, Jonsson E, Kristoffersson DT, McGill S. Rectal carcinoma: double-contrast MR imaging for preoperative staging. Radiology 2000;215:108-14.
25. Maier AG, Kersting-Sommerhoff B, Reeders JW, et al. Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: results of a multicenter phase II trial. J Magn Reson Imaging 2000;12:651-60.
26. Schnall MD, Furth EE, Rosato EF, Kressel HY. Rectal tumor stage: correlation of endorectal MR imaging and pathologic findings. Radiology 1994;190:709-14.
27. Hadfield MB, Nicholson AA, MacDonald AW, et al. Preoperative staging of rectal carcinoma by magnetic resonance imaging with a pelvic phased-array coil. Br J Surg 1997;84:529-31.
28. deSouza NM, Hall AS, Puni R, Gilderdale DJ, Young IR, Kmiot WA. High resolution magnetic resonance imaging of the anal sphincter using a dedicated endoanal coil: comparison of magnetic resonance imaging with surgical findings. Dis Colon Rectum 1996;39:926-34.
29. Blomqvist L, Machado M, Rubio C, et al. Rectal tumor staging: MR imaging using pelvic phased-array and endorectal coils vs. endoscopic ultrasonography. Eur Radiol 2000;10:653-60.
30. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumerfree resection margin in rectal cancer surgery. Lancet 2001;357:497-504.
31. Minsky BD, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer 1989;63:1421-9.
32. Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 1992;69:322-6.
33. Morson BC. Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med 1966;59:607-8.
34. Sitzler PJ, Seow-Choen F, Ho YH, Leong AP. Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum 1997;40:1472-6.
35. Saclarides TJ, Bhattacharyya AK, Britton-Kuzel C, Szeluga D, Economou SG. Predicting lymph node metastases in rectal cancer. Dis Colon Rectum 1994;37:52-7.
36. Morson BC. Histological criteria for local excision. Br J Surg 1985;72:S53-4.
37. Petrelli NJ, Letourneau R, Weber T, Nava ME, Rodriguez-Bigas M. Accuracy of biopsy and cytology for the preoperative diagnosis of colorectal adenocarcinoma. J Surg Oncol 1999;71:46-9.
38. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
39. Anonymous. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J Clin Oncol 1992;10:549-57.
40. Tveit, KM, Guldvog, I, Hagan, S, et al. Randomized controlled trial of post-operative radiotherapy and short term time scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997;84:1130-35.
41. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst. 2000;92:388-96.
42. O'Connell MJ, Martenson, JA, Wieand, HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7.
43. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic review of 8507 patients from 22 randomized trials. Lancet 2001;358:1291-304.
44. Hall EJ. The oxygen effect and the reoxygenation. In: Hall EJ, ed. Radiobiology for the radiologist. 3rd ed. London: Lippincott, 1987;137-60.
45. Minsky BD. Pelvic radiation therapy in rectal cancer. Sem Radiat Oncol 1993;3:42-7.
46. Minsky BD, Conti JA, Huang Y, et al. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 1995;13:1409-16.
47. Kirk J, Gray WM, Watson ER. Cumulative radiation effect. I. Fractionated treatment regimes. Clin Radiol 1971;22:145-55.
48. Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction-I: Comparison of the effects of daily and once-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984;10:593-8.
49. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
50. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990;211:187-95.
51. Anonymous. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.
52. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
53. Marijnen CA, Kapiteijn E, van De Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002;20:817-25.
54. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. Pathology Review Committee and the Cooperative Clinical Investigators. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001;19:1976-84.
55. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396.
56. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 1998;42:51-7.
57. Rouanet P, Fabre JM, Dubois J, et al. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg 1995;221:67-73.
58. Bosset JF, Horiot JC, Pavy JJ. Postoperative treatment of rectal cancer. In: Bleibery H, Rougier P, Wilke HJ, eds. Management of colorectal cancer. London: Martin Dunitz, 1998:345-9.
59. Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
60. Bosset JF, Pavy JJ, Hamers HP, et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose D, L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur J Cancer 1993;29A:1406-10.
61. Chan A, Wong A, Langevin J, et al. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791-9.
62. Chari RS, Tyler DS, Anscher MS, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778-87.
63. Landry, JC, Koretz, MJ, Wood, WC, et al. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology 1993;188:423-6.
64. Minsky BD, Cohen AM, Kemeny N, et al. Pre-operative combined 5-FU, low dose leucovorin and sequential radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1993;25:821-7.
65. Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993;71:3486-92.
66. Picciocchi A, Coco C, Magistrelli P, et al. Concomitant preoperative radiochemotherapy in operable locally advanced rectal cancer. Dis. Colon Rectum 1994;37(Suppl):S69-72.
67. Weinstein GD, Rich TA, Shumate CR, et al. Preoperatire infusional chemoradiation and surgery with or without electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:197-204.
68. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phvs 1995;32:1025-9.
69. Meade PG, Blatchford GJ, Thorson AG, et al. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am J Surg 1995;170:609-13.
70. Lowry AM, Rich TA, Skibber JM, et al. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma. Ann Surg 1996;223:177-85.
71. Grann, A, Minsky, BD, Cohen, AM, et al. Preliminary restults of preoperative 5-fluorouracil, low-dose leucovorin and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997;40:515-22.
72. Minsky BD, Cohen AM, Enker EW, et al. Combined modality therapy for rectal cancer: decreased acute toxicity with the pre-operative approach. J Clin Oncol 1992;10:1218-24.
73. Kuvshinoff B, Maghfoor I, Miedema B, et al. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient? Ann Surg Oncol 2001;8:163-9.
74. Hyams DM, Mamounas EP, Petrelli N et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol R0-3. Dis Colon Rectum 1997;40:131-9.
75. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal cancer. Int J Radiat Oncol Biol Phys 2001;49:987-95.
76. Valentini V, Coco C, Cellini N, et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1999;40:1067-75.
77. Mohiuddin M, Hayne M, Regine WF, et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;48:1075-80.
78. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal cancer. N Engl J Med 1985;312:1465-72.
79. Kollmorgen CF, Meagher AP, Pemberton JH, et al. The long term effect of adjuvant post-operative chemoradiotherapy for rectal cancer on bowel function. Ann Surg 1994;220:676-82.
80. Tjandra JJ, Reading DM, McLachlan SA, et al. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results. Dis Colon Rectum 2001;44:1113-22.
81. Ngan S, Ngan SY, Burmeister BH, Fisher R. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2001;50:883-7.
82. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
83. Glarakis IS, Savva S, Spandidos DA. Activation of the ras genes in malignant and premalignant colorectal tumors. Oncol Rep 1998;5:1451-4.
84. Pajkos G, Kiss I, Sandor J, Ember I, Kishazi P. Prognostic value of the presence of the mutation of the codons 12, 13 and 61 in K-ras oncogene in colorectal cancer. Orv Hetil 1999;140:1673-9.
85. Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000;119:921-8.
86. Williams NS, Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg 1983;70:460-2.
87. Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer: stoma vs. nonstoma patients. Dis Colon Rectum 1995;38:361-9.
88. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991;302:1501-5.
89. Phillips RK, Hittinger R, Blesovsy L, Fry JS, Fielding LP. Local recurrence following curative surgery for large bowel cancer. Br J Surg 1984;71:12-6.
90. Hermanek P, Hohenberger W. The importance of volume in colorectal cancer surgery. Eur Surg Oncol 1996;22:213-5.
91. Steele RJ. The influence of surgeon case volume on outcome in site-specific cancer surgery. Eur J Surg Oncol 1996;22:211-3.
92. Harmon JW, Tang DG, Gordon TA, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcome in colorectal resection. Ann Surg 1999;230:404-13.
93. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998;227:157-67.
94. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-6.
95. Devereux DF, Deckers PJ. Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma. Am J Surg 1985;149:323-6.
96. Kirwan WO, Drumm J, Hogan JM, Keohane C. Determining safe margin of resection in low anterior resection for rectal cancer. Br J Surg 1988;75:720-1.
97. Grinnell RS. Distal intramural spread of carcinoma of the rectum and rectosigmoid. Surg Gynecol Obstet 1954;99:421-30.
98. Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients survival. Br J Surg 1983;70:150-4.
99. Quer EA, Dahlin DC, Mayo CW. Retrograde intramural spread of carcinoma of the rectum and rectosigmoid. Surg Gynecol Obstet 1953;96:24-30.
100. Wolmark N, Fisher B. An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project. Ann Surg 1986;204:480-9.
101. De Haas-Kock DF, Baeten CG, Jager JJ. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996;83:781-5.
102. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
103. Goldberg PA, Nicholls RJ. Prediction of local recurrence and survival of carcinoma of the rectum by surgical and histopathological assessment of local recurrence. Br J Surg 1995;82:1054-6.
104. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-9.
105. Heald R, Ryall R. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-82.
106. Scott N, Jackson T, Al-Jaberi M, et al. Total mesorectal excision and local recurrence: a study of tumor spread in the mesorectum distal to rectal cancer. Br J Surg 1995;82:1031-3.
107. Reynolds J, Joyce W, Dolan J, et al. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996;83:1112-5.
108. Pollett W, Nicholls R. The relationship between the extent of the distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 1983;198:150-63.
109. Killingback M, Barron P, Dent OF. Local recurrence after curative resection of cancer of the rectum without total mesorectal excision. Dis Colon Rectum 2001;44:473-86.
110. Quirke P, Dixon M, Durdey P, Williams N. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986;2:996-9.
111. Stocchi I, Nelson H, Sargent D, Allmer C, Pepper J, Wisenfeld M. Impact of individual surgeon on rectal cancer outcome within 3 North Central Cancer Treatment Group (NCCTG) protocols [abstract]. Proc ASCO 1999;18:23a.
112. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 1997;184:584-8.
113. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimiters is the limit. Am J Surg Pathol 2002;26:350-7.
114. Stanetz CA Jr., Grimson R. Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer. Dis Colon Rectum 1997;40:1205-19.
115. Grinnell RS. Results of ligation of inferior mesenteric artery at the aorta in resections of carcinoma of the descending and sigmoid colon and rectum. Surg Gynecol Obstet 1965;120:1031-6.
116. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583-96.
117. Bonfanti G, Bozzaetti F, Doci R, et al. Results of extended surgery for cancer of the rectum and sigmoid. Br J Surg 1982;69:305-7.
118. Eldar S, Kemeny MM, Terz JJ. Extended resections for carcinoma of the colon and rectum. Surg Gynecol Obstet 1985;161:319-22.
119. Lopez MJ, Monafo WW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 1993;113:365-72.
120. Hunter JA, Ryan JA Jr., Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg 1987;154:67-71.
121. Sugarbaker PH, Corlew S. Influence of surgical techniques on survival in patients with colorectal cancer: a review. Dis Colon Rectum 1982;25:545-57.
122. Orkin BA, Dozois RR, Beart RW Jr., Patterson DE, Gunderson LL, Ilstrup DM. Extended resection for locally advanced primary adenocarcinoma of the rectum. Dis Colon Rectum 1989;32:286-92.
123. Tatamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet 1993;177:481-7.
124. Skipper D, Cooper AJ, Marston JE, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049-52.
125. Docherty JG, McGregor JR, Purdie CA, et al. Efficacy of tumoricidal agents in vitro and in vivo. Br J Surg 1995;82:1050-2.
126. Rosenberg IL, Russell CW, Giles GR. Cell viability studies on the exfoliated colonic cancer cell. Br J Surg 1978;65:188-90.
127. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990;33:610-4.
128. Porter GA, O'Keefe GE, Yakimets WW. Inadvertent perforation of the rectum during abdominoperineal resection. Am J Surg 1996;172:324-7.
129. Slanetz CA Jr. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 1984;27:792-7.
130. Roh MS, Petrelli N, Wieand S, et al. Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). Proc Am Soc Clin Oncol 2001;20:A490.
131. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001;177:173-81.
132. Sauer R, Fietkau R, Rodel C, et al. Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer - First results of the German multicenter phase III - Trial (protocol CAO/ARO/AIO-94). ESTRO 2002;21:115A.
133. Bujko K, Nowacki M, Bebenek M, et al. Randomized trial comparing high dose per fraction preoperative radiotherapy with immediate surgery vs. conventional radiochemotherapy with delayed surgery for patients with low rectal cancer. ESTRO 2002;21:140A.